Candida guilliermondii and other species of candida misidentified as Candida famata: assessment by vitek 2, DNA sequencing analysis, and matrix-assisted laser desorption ionization-time of flight mass spectrometry in two global antifungal surveillan

Candida guilliermondii and other species of candida misidentified as Candida famata: assessment by vitek 2, DNA sequencing analysis, and matrix-assisted laser desorption ionization-time of flight mass spectrometry in two global antifungal surveillan

Item

http://www.wikidata.org/entity/Q34458142

Q34458142

about

Invasive candidiasis in non neutropenic critically ill - need for region-specific management guidelines Are the Conventional Commercial Yeast Identification Methods Still Helpful in the Era of New Clinical Microbiology Diagnostics? A Meta-Analysis of Their Accuracy Reliable differentiation of Meyerozyma guilliermondii from Meyerozyma caribbica by internal transcribed spacer restriction fingerprinting.Regional data analysis of Candida non-albicans strains collected in United States medical sites over a 6-year period, 2006-2011.Epidemiology and outcomes of invasive candidiasis due to non-albicans species of Candida in 2,496 patients: data from the Prospective Antifungal Therapy (PATH) registry 2004-2008.In vitro antifungal susceptibilities of isolates of Candida spp. and Aspergillus spp. from China to nine systemically active antifungal agents: data from the SENTRY antifungal surveillance program, 2010 through 2012.Auxanographic Carbohydrate Assimilation Method for Large Scale Yeast Identification Accuracy of matrix-assisted laser desorption ionization-time of flight mass spectrometry for identification of clinical pathogenic fungi: a meta-analysis.Three clustered cases of candidemia caused by Candida quercitrusa and mycological characteristics of this novel species Comparison of the accuracy of two conventional phenotypic methods and two MALDI-TOF MS systems with that of DNA sequencing analysis for correctly identifying clinically encountered yeasts.MALDI-TOF-MS-based species identification and typing approaches in medical mycology.Matrix-assisted laser desorption ionization-time of flight mass spectrometry in clinical microbiology.Efficient identification of Malassezia yeasts by matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS).Development of two molecular approaches for differentiation of clinically relevant yeast species closely related to Candida guilliermondii and Candida famata.Comparison and optimization of two MALDI-TOF MS platforms for the identification of medically relevant yeast species.Antifungal susceptibility profiles of bloodstream yeast isolates by Sensititre YeastOne over nine years at a large Italian teaching hospital.Comparison of Vitek Matrix-assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry Versus Conventional Methods in Candida Identification.Misidentification of a Rare Species, Cryptococcus laurentii, by Commonly Used Commercial Biochemical Methods and Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry Systems: Challenges for Clinical Mycology Laboratories.In vitro activities of isavuconazole and comparator antifungal agents tested against a global collection of opportunistic yeasts and molds.Echinocandin and triazole antifungal susceptibility profiles for clinical opportunistic yeast and mold isolates collected from 2010 to 2011: application of new CLSI clinical breakpoints and epidemiological cutoff values for characterization of geogr Comparative analyses of classical phenotypic method and ribosomal RNA gene sequencing for identification of medically relevant Candida species.The Candida pathogenic species complex.Candida guilliermondii: biotechnological applications, perspectives for biological control, emerging clinical importance and recent advances in genetics.Epidemiology and antifungal susceptibilities of yeast isolates causing invasive infections across urban Beijing, China.The halotolerant Debaryomyces hansenii, the Cinderella of non-conventional yeasts.Candida fermentati as a cause of persistent fungemia in a preterm neonate successfully treated by combination therapy with amphotericin B and caspofungin.Differential Activity of the Oral Glucan Synthase Inhibitor SCY-078 against Wild-Type and Echinocandin-Resistant Strains of Candida Species.Characterization of Candida famata Isolated from Poultry Feces for Possible Probiotic Applications.Breakthrough fungemia due to Candida fermentati with fks1p mutation under micafungin treatment in a cord blood transplant recipient.Molecular Identification of Candida Species Isolated from Onychomycosis in Shanghai, China.Comparative evaluation of BD Phoenix and vitek 2 systems for species identification of common and uncommon pathogenic yeasts.False-positive reaction of L-canavanine glycine bromothymol blue medium with Candida famata.Looking into the virulence of Candida parapsilosis: a diagnostic perspective.Three cases of candidiasis misidentified as Candida famata by the Vitek 2 system.Monitoring Antifungal Resistance in a Global Collection of Invasive Yeasts and Molds: Application of CLSI Epidemiological Cutoff Values and Whole-Genome Sequencing Analysis for Detection of Azole Resistance in Candida albicans.Isavuconazole and nine comparator antifungal susceptibility profiles for common and uncommon Candida species collected in 2012: application of new CLSI clinical breakpoints and epidemiological cutoff values.

P2860

Q26801500-70CE0D22-BCD0-4943-BA0D-8F4315CA14B6 Q28084765-AC827B2C-8DA1-4460-B870-ACCFD802A798 Q30392109-9F70488D-B0C0-45D3-A023-4CE4BABC80AA Q30826889-07063B43-1A98-46DF-B4CD-F2885DD6C9D9 Q30834974-20371F7A-6637-4C35-A4A5-9EA90B2698C3 Q30902025-27C0AE33-A961-4569-8AB3-5BE819362CB8 Q33741532-3CFB2CBA-F4EF-438B-B60B-1F1CF278F940 Q33900027-10319FD8-0AE9-4AD3-B37C-F53C47942007 Q34058629-1351826C-6C49-48A6-B805-C8B236840D71 Q34351558-717C2AD2-03C3-4FA3-9268-EBBFB1300F4E Q34529370-E1117004-D824-4ED1-854B-9A72CF2466C5 Q34675879-3C7869AA-10FC-41BC-B8B1-EB557A4CCC17 Q35017266-AB33D511-1632-4529-92DE-AAED7E05E1BC Q35035707-9BBBEB3B-FFF9-4AD9-B4D0-4D78C53D25B3 Q35163632-57072A91-D0AE-4510-9674-42A788F755C8 Q35746090-862B76F5-A294-4FC8-A4F9-0133844B8591 Q35786180-C6312C60-032B-46F8-B75E-1F511FCC0BBA Q35839167-16999C32-C94F-403E-B743-4CD5696087C5 Q37036173-BF896970-4792-4AF8-9DEC-96F73B203207 Q37036246-9586C16E-D91A-485C-B428-87B0BD8258F5 Q37675305-1093419E-280C-40C1-9BF7-16915199BD2F Q38245727-E8D62C87-E6C1-4AF4-8762-583BB61B03A8 Q38490686-426F91A3-B8AA-4AC7-ACE8-3023EF52E3B2 Q38610744-1081E261-D78C-4C2C-A499-74632053865B Q38859796-558F1DEE-4BDF-4353-94C9-1A73F82AD6C3 Q39420285-115CFD0F-C575-403E-A439-570D0943045C Q40202924-2DB43776-BA33-436A-A417-211BD3B806CF Q40440288-55BF101B-6BC5-450C-86F0-1A48718EE5AE Q40446419-7B6292BB-566A-4B39-A234-7FCB64C29647 Q40676298-17FE1A06-5AE8-4501-B4E9-57244E2BC79B Q41868077-684B8160-D216-4746-8A78-1E4D898BE3DC Q42341446-1482B093-45BA-4289-ADF2-8F0002BDA85B Q42702754-44F8E47D-4EC0-4554-BC15-69B6E5CC48B2 Q43074742-1A8493AF-13A6-4723-8F56-8812651CD83A Q46324582-F73ABF82-2D75-471C-817B-8C1D3FC2EB77 Q46876288-0E31A312-7E2F-459F-90D8-D10CE92D5D58

P2860

Candida guilliermondii and other species of candida misidentified as Candida famata: assessment by vitek 2, DNA sequencing analysis, and matrix-assisted laser desorption ionization-time of flight mass spectrometry in two global antifungal surveillan

Item

http://www.wikidata.org/entity/Q34458142

description

2012 nî lūn-bûn

@nan

2012 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu